JP2016521286A5 - - Google Patents

Download PDF

Info

Publication number
JP2016521286A5
JP2016521286A5 JP2016513125A JP2016513125A JP2016521286A5 JP 2016521286 A5 JP2016521286 A5 JP 2016521286A5 JP 2016513125 A JP2016513125 A JP 2016513125A JP 2016513125 A JP2016513125 A JP 2016513125A JP 2016521286 A5 JP2016521286 A5 JP 2016521286A5
Authority
JP
Japan
Prior art keywords
weeks
nutritional supplement
lipid
cancer
diet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016513125A
Other languages
English (en)
Japanese (ja)
Other versions
JP6533519B2 (ja
JP2016521286A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/037514 external-priority patent/WO2014183047A1/en
Publication of JP2016521286A publication Critical patent/JP2016521286A/ja
Publication of JP2016521286A5 publication Critical patent/JP2016521286A5/ja
Priority to JP2019097670A priority Critical patent/JP6970709B2/ja
Application granted granted Critical
Publication of JP6533519B2 publication Critical patent/JP6533519B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016513125A 2013-05-10 2014-05-09 Rasがんにおける脂質捕捉 Active JP6533519B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019097670A JP6970709B2 (ja) 2013-05-10 2019-05-24 Rasがんにおける脂質捕捉

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361822095P 2013-05-10 2013-05-10
US61/822,095 2013-05-10
PCT/US2014/037514 WO2014183047A1 (en) 2013-05-10 2014-05-09 Lipid scavenging in ras cancers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019097670A Division JP6970709B2 (ja) 2013-05-10 2019-05-24 Rasがんにおける脂質捕捉

Publications (3)

Publication Number Publication Date
JP2016521286A JP2016521286A (ja) 2016-07-21
JP2016521286A5 true JP2016521286A5 (enExample) 2017-06-15
JP6533519B2 JP6533519B2 (ja) 2019-06-19

Family

ID=51867773

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016513125A Active JP6533519B2 (ja) 2013-05-10 2014-05-09 Rasがんにおける脂質捕捉
JP2019097670A Active JP6970709B2 (ja) 2013-05-10 2019-05-24 Rasがんにおける脂質捕捉

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019097670A Active JP6970709B2 (ja) 2013-05-10 2019-05-24 Rasがんにおける脂質捕捉

Country Status (7)

Country Link
US (2) US10130600B2 (enExample)
EP (1) EP2993980B1 (enExample)
JP (2) JP6533519B2 (enExample)
AU (3) AU2014262450A1 (enExample)
CA (2) CA2912052C (enExample)
IL (2) IL242492B (enExample)
WO (1) WO2014183047A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338109B2 (en) 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
CA2725978A1 (en) 2008-05-28 2009-12-03 Genomedx Biosciences, Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
US8669057B2 (en) 2009-05-07 2014-03-11 Veracyte, Inc. Methods and compositions for diagnosis of thyroid conditions
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
US20130267443A1 (en) 2010-11-19 2013-10-10 The Regents Of The University Of Michigan ncRNA AND USES THEREOF
US10513737B2 (en) 2011-12-13 2019-12-24 Decipher Biosciences, Inc. Cancer diagnostics using non-coding transcripts
ES3015226T3 (en) 2012-08-16 2025-04-30 Veracyte Sd Inc Prostate cancer prognosis using biomarkers
WO2014186036A1 (en) 2013-03-14 2014-11-20 Allegro Diagnostics Corp. Methods for evaluating copd status
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
EP2993980B1 (en) 2013-05-10 2023-11-01 Memorial Sloan Kettering Cancer Center Lipid scavenging in ras cancers
US11369588B2 (en) 2014-03-20 2022-06-28 The Trustees Of Princeton University NADPH production by the 10-formyl-THF pathway, and its use in the diagnosis and treatment of disease
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
CN114606309A (zh) 2014-11-05 2022-06-10 威拉赛特公司 使用机器学习和高维转录数据的诊断系统和方法
US11414708B2 (en) 2016-08-24 2022-08-16 Decipher Biosciences, Inc. Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
AU2018210695B2 (en) 2017-01-20 2024-07-18 The University Of British Columbia Molecular subtyping, prognosis, and treatment of bladder cancer
WO2018165600A1 (en) 2017-03-09 2018-09-13 Genomedx Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
US11078542B2 (en) 2017-05-12 2021-08-03 Decipher Biosciences, Inc. Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
AU2018310987A1 (en) 2017-08-04 2020-02-27 Decipher Biosciences, Inc. Use of immune cell-specific gene expression for prognosis of prostate cancer and prediction of responsiveness to radiation therapy

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07509470A (ja) * 1992-07-24 1995-10-19 ザ・ジョーンズ・ホプキンス・ユニバーシティ がんの治療に脂肪酸合成阻害剤を用いる方法
US6156504A (en) 1996-03-15 2000-12-05 The Penn State Research Foundation Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays
US6214875B1 (en) * 1998-04-14 2001-04-10 Zhenhua Yang Anticancer effects of specific branched-chain fatty acids and related production process
CA2519773C (en) 2003-03-27 2014-02-18 Kengo Akimoto Lipid-improving agent and composition containing lipid-improving agent
US8092839B2 (en) * 2004-12-13 2012-01-10 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer and other diseases
US8652508B2 (en) * 2007-05-25 2014-02-18 Children's Medical Center Corporation Dietary formulations and methods for treatment of inflammation and other disorders
US20100129430A1 (en) * 2008-11-24 2010-05-27 Stavroula Sofou Liposome drug carriers with ph-sensitivity
TWI629992B (zh) 2011-05-27 2018-07-21 明治股份有限公司 用於預防以及/或者改善癌症引起的非可逆性的代謝紊亂的組合物
RS56394B1 (sr) * 2011-06-15 2017-12-29 Stable Solutions Llc Terapeutska primena parenteralnog kril ulja
EP2993980B1 (en) 2013-05-10 2023-11-01 Memorial Sloan Kettering Cancer Center Lipid scavenging in ras cancers

Similar Documents

Publication Publication Date Title
Chen et al. Fish oil attenuates liver injury caused by LPS in weaned pigs associated with inhibition of TLR4 and nucleotide-binding oligomerization domain protein signaling pathways
PH12018500036A1 (en) Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
JP2019147836A5 (enExample)
ES2810323T3 (es) Agente antiinflamatorio que contiene ácido graso raro
MX388553B (es) Composiciones nutritivas de triglicèridos de cadena media para la protección de la vàlvula mitral en animales de compañìa.
PH12017502181A1 (en) Nutritional compositions containing an elevated level of inositol and uses thereof
PH12018500035A1 (en) Nutritional compositions and methods for promoting cognitive development
MX2022011742A (es) Composicion nutritiva para el entorno gastrointestinal para proporcionar microbioma y perfil metabolico mejorados.
PH12016501952A1 (en) Nutritional compositions directed to subjects having cow`s milk protein allergies
Jung et al. Quality assessment of the breast meat from WoorimatdagTM and broilers
MX2016006675A (es) Producción de ácidos grasos poliinsaturados de cadena larga omega 3 en los cultivos de oleaginosas por una sintasa de pufa proveniente de traustoquitridio.
Zuo et al. Molecular cloning, tissue distribution and nutritional regulation of a Δ6‐fatty acyl desaturase‐like enzyme in large yellow croaker (L arimichthys crocea)
CA2905817A1 (en) Reducing the risk of autoimmune disease
RU2015133023A (ru) Активация адипонектина с использованием гидролизата казеина
MX2015012548A (es) Metodos para estimular la maduracion de pulmones e intestinos infantiles.
Shu et al. Effect of ascorbic acid and cysteine hydrochloride on growth of Bifidobacterium bifidum
WO2017132445A8 (en) Clinical regimen for treating myelodysplastic syndrome with phosphatase inhibitor
Minarny et al. Fatty acid profile of fish from Central Sulawesi, Indonesia.
PH12017500738A1 (en) Feeding algae to cattle at low doses to produce high omega 3 levels in beef
SG10201903120YA (en) Nutritional composition comprising whey and hydrolyzed casein and uses thereof
PH12017500740A1 (en) Nutritional supplements containing a peptide component and uses thereof
UA86387U (ru) Способ оценки эффективности лечения больных с артериальной гипертензией, объединенной с метаболическим синдромом
Jorjani et al. Comparison of Chemical Compositions and Fatty Acid Profile of Cultured Common Carp (Cyprinus carpio) and Silver Carp (Hypophthalmichthys molitrix)
林雪麗 et al. Duckweed (Lemna minor), as a potential protein source for red tilapia (Oreochromis sp.)
Yoshii et al. Impact of EPA nutritional approach on cachexic patients with advanced hypopharyngeal cancer treated by induction chemotherapy